WealthGarden F.S.’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
WealthGarden F.S.'s ABBV Position: Q2 2026 in Review
WealthGarden F.S. increased its AbbVie (ABBV) stake by 28% in Q2 2026, buying an estimated $99K and bringing the position to 2,123 shares worth $534K. The position accounts for 0.3% of the portfolio, ranked #94.
WealthGarden F.S. first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- WealthGarden F.S. held 2,123 shares of AbbVie worth $534K as of Q2 2026.
- WealthGarden F.S. bought 460 AbbVie shares in Q2 2026, an estimated $99K.
- AbbVie made up 0.3% of WealthGarden F.S.'s portfolio in Q2 2026, its #94 holding.
- WealthGarden F.S. first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on WealthGarden F.S.'s 13F filing for Q2 2026, filed 31 Jul 2026.